ArticleOncotarget2016

Comparative efficacy and safety of first-line treatments in patients with metastatic renal cell cancer: a network meta-analysis based on phase 3 RCTs.

Xiaofeng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.